Association between quantitative CT body composition analysis and prognosis in cetuximab-based first-line treatment for advanced colorectal cancer patients
Wenxi Dang, Shusheng Wu, Xudong Liu, Hao Shen, Yaolin Chen, Zhihua Zhang et al. Association between quantitative CT body composition analysis and prognosis in cetuximab-based first-line treatment for advanced colorectal cancer patients. // BMC Cancer. – 2024. – DOI: 10.1186/s12885-024-13338-8. – URL: https://doi.org/10.1186/s12885-024-13338-8
Wenxi Dang, Shusheng Wu, Xudong Liu, Hao Shen, Yaolin Chen, Zhihua Zhang, Haoyu Wang, Zhirun Cai, Mengge Li, Mingjie Sun, Fei Gao, & Yifu He (2024). Association between quantitative CT body composition analysis and prognosis in cetuximab-based first-line treatment for advanced colorectal cancer patients. BMC Cancer. https://doi.org/10.1186/s12885-024-13338-8
Wenxi Dang, et al. “Association between quantitative CT body composition analysis and prognosis in cetuximab-based first-line treatment for advanced colorectal cancer patients.” BMC Cancer, 2024. doi:10.1186/s12885-024-13338-8.
@article{Dang2024,
title = {Association between quantitative CT body composition analysis and prognosis in cetuximab-based first-line treatment for advanced colorectal cancer patients},
author = {Dang, Wenxi and Wu, Shusheng and Liu, Xudong and Shen, Hao and Chen, Yaolin and Zhang, Zhihua and Wang, Haoyu and Cai, Zhirun and Li, Mengge and Sun, Mingjie and Gao, Fei and He, Yifu},
journal = {BMC Cancer},
year = {2024},
doi = {10.1186/s12885-024-13338-8},
url = {https://doi.org/10.1186/s12885-024-13338-8}
}